566 filings
Page 5 of 29
8-K
hssrwm
25 Feb 21
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
t4h0j7ntlt
23 Feb 21
Regulation FD Disclosure
10:55am
8-K
qnq7665p ozkewod
12 Feb 21
Departure of Directors or Certain Officers
4:31pm
424B5
dpmqt
28 Jan 21
Prospectus supplement for primary offering
4:32pm
8-K
sjd58t
28 Jan 21
TransEnterix Announces $25 Million Bought Deal Offering of Common Stock
4:05pm
FWP
rljh6d9j8 lmgj
27 Jan 21
Free writing prospectus
8:38am
FWP
rx9 o8h88j2560nlss74
27 Jan 21
Free writing prospectus
8:38am
S-3MEF
4n4x9rk9arpx30o
26 Jan 21
Registration of additional securities for an S-3
10:00pm
FWP
be9xuhnzl6tflzsomh
26 Jan 21
Free writing prospectus
5:28pm
424B5
18mpi
26 Jan 21
Prospectus supplement for primary offering
5:18pm
8-K
7dv4tw2db0g
19 Jan 21
TransEnterix Receives CE Mark for Machine Vision System in Robotic Surgery
4:31pm
424B5
1e9uobdoz2r96 l0f
14 Jan 21
Prospectus supplement for primary offering
6:56am
8-K
rftjfvl gq28tak4mb
14 Jan 21
TransEnterix Announces $31.25 Million Registered Direct Offering of Common Stock
6:31am
8-K
15xvznno4trf aueel
6 Jan 21
TransEnterix Provides Preliminary 2020 Year-End Corporate Update
7:03am
8-K
siwyq
17 Dec 20
TransEnterix Announces Southern Surgical Hospital to Initiate a Senhance® Digital Laparoscopic Program
6:55am
8-K
m6aw8yfu9lh
16 Dec 20
TransEnterix Announces Approval of Senhance® Surgical System in Russian Federation
8:01am
8-K
8zwcgpv
9 Nov 20
TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2020
5:10pm
S-8
y5p3l
6 Nov 20
Registration of securities for employees
12:00am
424B5
l49j3orbdl0
9 Oct 20
Prospectus supplement for primary offering
5:25pm